Novo Nordisk Finds Responsible Production In Unusual Places
Do you want to know how Novo Nordisk’s production sites are doing their part to create a healthier and cleaner planet? Find out in the Q2 issue of Novo Nordisk’s sustainability magazine – The TBL Quarterly.
August 27, 2013 /3BL Media/ – Today, Novo Nordisk publishes its second issue of the company’s digital sustainability magazine – The TBL Quarterly. The content in the new issue, Responsible Production, explores the successes and challenges of managing the company’s environmental impact at its global insulin production sites.
Novo Nordisk’s TBL Quarterly is available as a downloadable Adobe PDF and as an iPad app. Click here to explore both versions.
From the Brazilian savannah to the French production floor
The latest issue of the TB Quarterly demonstrates Novo Nordisk’s global strategy to reduce CO2 emissions, energy use, water consumption and waste through local production site initiatives.
Articles include the story of NovoECO, an initiative in Brazil where conservation of the local Cerrado savannah has led to both water and waste reductions and a new recreational area for the employees. In China, considerable energy savings have been made by thinking energy savings into the early design of the production site. In France, setting ambitious water reduction goals has spurred innovation among employees on the production floor leading to a 79% reduction in water consumption.
Also included in the latest issue are examples of how employees volunteer to give back to the communities, how Novo Nordisk works in partnership with the UK’s National Health Service (NHS) to find new ways to reduce NHS’ CO2 emissions, and a Q&A with two energy stewards from the production site in Tianjin, China who have made a career out of searching for energy savings.
About the TBL Quarterly
Novo Nordisk manages its business in accordance with the Triple Bottom Line (TBL) business principle and pursues business solutions that maximise value to both stakeholders and shareholders. Published following the company’s quarterly results, Novo Nordisk’s TBL Quarterly offers articles, photos, videos and infographics that demonstrate how responsibility supports long-term value creation. The TBL Quarterly is available in PDF and as a reader-friendly application for iPad. Download previous and the new TBL Quarterly
About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2013, Novo Nordisk received the Pharmaceuticals and Biotechnology industry group top ranking on Corporate Knight’s list of Global 100 Most Sustainable Corporations.
